Key Metrics of Bio-Rad Laboratories
Revenue$2.7B▼ 4.7% YoYFY 2023
Operating income$338M▼ 30.0% YoY
Net profit−$637M▲ 82.4% YoY
Shareholders' equity$8.7B
Market cap$9.7BBIO · $363.50
Competitors10identified
About Bio-Rad Laboratories
Sectors
Company details
- Website
- bio-rad.com
- Founded
- 1980
- Registered office
- 9th Floor, Tower A, Emaar Digital Greens Sector 61, Golf Course Extension, Gurgaon, Gurgaon, In-hr, 122102
- Listed
- NYSE: BIO · NYSE: BIO-B (since 1980)
Operational Areas of Bio-Rad Laboratories
Pharmaceuticals & Healthcare›Biotechnology & Vaccines
Company summary
Entity details
CINU32109HR1996PTC107956
LEI code335800M8I2UYEQ7KI778
State codeHR
PIN code122102
Current legal nameBIO-RAD LABORATORIES
Classification—
Listing statusUnlisted
Registration no.107956
Company age—
PAN—
CountryUnited States
CityGurgaon
StateHaryana
Current statusActive
Date of incorporation—
Registrar of companies—
Authorised capital—
Paid-up capital—
Employee count—
Compliance
Last AGM date—
Last balance sheet—
Next filing dueAOC-4 for FY 2025-26 · 30 Oct 2026
Industry classification
NIC code32109
Description of main activityManufacture of radio, television and communication equipment
Description of business activityManufacture of radio, television and communication equipment
SectorPharmaceuticals & Healthcare · Biotechnology & Vaccines
US market & SEC filings
BIO · NYSE | BIO-B · NYSE · SEC CIK 0000012208
Last price · 25 Oct 2026
$363.50
+0.83%
Market cap$9.7B
P/E—On FY 2023 diluted EPS
Volume228,282
SectorIndustrialsBiotechnology: Laboratory Analytical Instruments
Country · IPOUnited StatesListed 1980
BIO share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingFiling compliance
AGM for FY 2025-2630 Sep 2026
Statutory due date passed
AOC-4 for FY 2025-2630 Oct 2026
Statutory due date · 4 days left
MGT-7 for FY 2025-2629 Nov 2026
Statutory due date · 34 days left
Due dates follow the Companies Act: AGM within six months of the year end, AOC-4 within 30 days and MGT-7 within 60 days of the AGM. A filing made but not yet uploaded here shows as pending.
Vendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered office9TH FLOOR, TOWER A, EMAAR DIGITAL GREENS SECTOR 61, GOLF COURSE EXTENSION, GURGAON, GURGAON, IN-HR, 122102
GSTIN—
Email—
Websitehttp://www.bio-rad.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Bio-Rad Laboratories
Competitors10identified
Locations1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Part of Vertex Pharmaceuticals. | vrtx.com | 1991 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | modernatx.com | 2018 | United States | |
 Becton Dickinson |
Biotechnology & Vaccines · Pharmaceuticals & Healthcare | bd.com | — | United States |
| Part of Illumina. | illumina.com | 2000 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | guardanthealth.com | 2018 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | revvity.com | — | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | exelixis.com | 2000 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | neurocrine.com | 1996 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | biomarin.com | 1999 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | 10xgenomics.com | 2019 | United States |
Similar companies
C
Concord Biotech LimitedPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
1
10X GenomicsPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
B
Beam TherapeuticsPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
E
ExelixisPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
G
Guardant HealthPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
N
Neurocrine BiosciencesPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
B
BioMarin PharmaceuticalPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
T
Twist BiosciencePharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Group companies
Business activities and related parties
biotechnology
Filings
No filings on record yet.